The Main Neurological Dysfunctions in Hyperargininemia-Literature ReviewFranzoi et al. Int J Neurol Neurother 2018, 5:074 Citation: Franzoi AEA, Patti MM, Magro DDD, de Lima

Myocyte-mediated Arginase Expression Controls Hyperargininemia but not Hyperammonemia in Arginase-deficient Miceoriginal article © The American Society of Gene &

Arginase 1 deficiency presenting as complicated hereditary spastic paraplegiaPaulo Ribeiro Nóbrega,1,2 Anderson Rodrigues Brandão de Paiva,1,3 Bruno Della-Ripa,1

(Microsoft Word - TESE DOUTORADO D\311BORA 2.doc)UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL ESTUDOS SOBRE OS MECANISMOS DAS ALTERAÇÕES DO METABOLISMO ENERGÉTICO

Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiencyOR I G I N A L AR T I C L E Clinical effect and safety profile of pegzilarginase

Newborn Screening for Disorders of Amino Acid MetabolismCycle Metabolism, and Organic acid  Metabolism AMINO ACIDS • Amino acids are the building blocks that proteins 

Arginase deficiencyArginase deficiency Description Arginase deficiency is an inherited disorder that causes the amino acid arginine (a building block of proteins) and ammonia

jon_217_LRNeuroimaging Findings in Hyperargininemia Serdal Gungor, Aysehan Aknc, Ahmet Kemal Frat, Ylmaz Tabel, Alpay Alkan From the Inonu University, Faculty of Medicine,

Supported by as a service to metabolic medicine BASED ON THE ORIGINAL TEMPLE WRITTEN BY BURGARD AND WENDEL VERSION 2, NOVEMBER 2020 ADAPTED BY THE DIETITIANS GROUP British

Long-term Survival of the Juvenile Lethal Arginase-deficient Mouse With AAV Gene Therapy1844 www.moleculartherapy.org vol. 20 no. 10, 1844–1851 oct. 2012 © The